Cloud Banner

Healthcare

Image

Global Biological Buffers Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Biological Buffers Market, By Product Type (Phosphates Type, Acetates Type, TRIS Type, Others), Applications (Research Institution, Pharmaceutical Industry, Others) – Industry Trends and Forecast to 2030.

Biological Buffers Market

Biological Buffers Market Analysis and Size

Most buffers are made up of a weak acid and a weak base. They aid in maintaining a specific pH even after adding an acid or a base. For instance, a buffer system of carbonic acid (H2CO3) and bicarbonate (HCO3-) is present in blood. In this system, a little amount of weak acid dissociation occurs, producing bicarbonate ions. Extra H+ions in the blood can be bound by these ions. By reforming the weak acid, this also lowers the concentration of H+ ions in the solution.

Data Bridge Market Research analyses that the biological buffers market, which was USD 0.69 billion in 2022, is expected to reach USD 1.3 billion by 2030, at a CAGR of 7.50% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Biological Buffers Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Phosphates Type, Acetates Type, TRIS Type, Others), Applications (Research Institution, Pharmaceutical Industry, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Lilly (U.S.), Merck & Co., Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Endo Pharmaceuticals plc (Ireland), Zydus Group (India), Bausch Health Companies Inc. (Canada)

Market Opportunities

  • Application of buffer on living cell
  • Buffer in biological systems

Market Definition

Biological buffers are used to create unique solutions that aid in various biochemical processes in which a significant change in pH can cause harmful reactions in molecular structure, biological activity, and functions. Buffer systems are aqueous systems that resist pH changes caused by adding an acid or base. A weak conjugate acid-base pair makes up a buffer solution. A weak acid and its conjugate base, for example, or a weak base and its conjugate acid. When small amounts of other acids or bases are added to the solution, they are neutralized, and the solution resists pH changes.

Global Biological Buffers Market Dynamics

Drivers

  • Rising demand for blood

The blood buffers consists of the plasma proteins, hemoglobin, oxy-hemoglobin, bicarbonates and inorganic phosphates. Even though the biological buffer market is being driven by rising demand for blood and blood plasma for transfusion purposes and ongoing vaccination programs against polio, rubella, and other such diseases, these factors boost the market's growth.

  • Application of buffer on living cell

Living cells require consistent conditions to survive. Individual living cells not part of a larger organism rely on their surroundings for a consistent supply of nutrients, oxygen, and salt balance. Furthermore, their surroundings must maintain a near-constant temperature and pH level. If any of these physical and chemical parameters changes, the living conditions may shift above or below the optimum levels required for survival. Organisms may be unable to develop or reproduce under these conditions. The organism's life may be jeopardized if the conditions are changed further.

Opportunities

  • Buffer in biological systems

In the solution, a weak acid and its associated salt (acetic acid and sodium acetate) protect by preserving equilibrium through ion transfer and neutralization. Combining two acid salts produces the same effect; popular buffering agents include phosphates, carbonates, and ammonium salts. The ability of most intact biological entities to withstand significant pH changes is an important feature. Large pH changes are not tolerated by the cytoplasmic fluid, which contains dissolved proteins, organic substrates, and inorganic salts. Blood plasma is a highly effective buffer solution, almost perfectly designed to maintain the blood pH between 7.2 and 7.3. These are certain factors that propel the growth of the market.

Restraints/Challenges

  • Complications associated with the preparation of buffer

Biochemical reactions are especially sensitive to pH. On the other hand, the market's highly competitive nature is expected to hamper growth. Complications associated with the preparation of buffer solutions are expected to challenge the market during the forecast period.

This biological buffers market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biological buffers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Biological Buffers Market Scope

The biological buffers market is segmented on the basis of product type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Phosphates Type
  • Acetates Type
  • TRIS Type
  • Others

 Applications

  • Research Institution
  • Pharmaceutical Industry
  • Others

Biological Buffers Market Regional Analysis/Insights

The biological buffers market is analysed and market size insights and trends are provided by country, product type and application as referenced above.

The countries covered in the biological buffers market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the biological buffers market due to high investments by major companies in technological advancements and product development. Moreover, growing government funding for research activities is also anticipated to propel growth over the coming years.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the increasing awareness among people regarding health and fitness coupled with rapid urbanization resulting in increased pollution levels.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Biological Buffers Market Share Analysis

The biological buffers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biological buffers market.

Some of the major players operating in the biological buffers market are:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • Lilly (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Endo Pharmaceuticals plc (Ireland)
  • Zydus Group (India)
  • Bausch Health Companies Inc. (Canada) 


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The biological buffers market value was USD 0.69 billion in 2022.
The biological buffers market is projected to grow at a CAGR of 7.50% during the forecast period of 2023-2030.
The Biological Buffers Market report is segmented by Product Type and Applications.
North America dominates the biological buffers market due to high investments by major companies in technological advancements and product development.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials